Abstract 3100: Blinatumomab is safe and effective in relapsed and MRD positive B-ALL CD19+ patients: The bologna compassionate program experienceGiovanni Martinelli, Cristina Papayannidis, Stefania Paolini et al.|Clinical Research (Excluding Clinical Trials)|2019Cited by 0
Abstract 3100: Blinatumomab is safe and effective in relapsed and MRD positive B-ALL CD19+ patients: The bologna compassionate program experienceGiovanni Martinelli, Cristina Papayannidis, Valentina Robustelli et al.|Cancer Research|2019Cited by 0